A Brief Discussion on Neuroprotection in Neurological Disorders

Author(s): Mark Torres

In clinical practice, neurological disorders that affect the nervous system and have different causes are common. Functional RNA molecules with a length greater than 200 nucleotides that participate in essential functions but do not encode proteins are referred to as long non-coding RNA (lncRNA) molecules. lncRNAs may play a role in the pathogenesis of neurological disorders and may be therapeutic targets, according to research. Phytochemicals in customary Chinese natural medication (CHM) have been found to apply neuroprotective impacts by focusing on lncRNAs and directing quality articulation and different flagging pathways. Through a comprehensive literature review, our goal is to determine the development status and neuroprotective mechanism of phytochemicals that target lncRNAs. From the beginning to September 2022, manual and electronic searches of the PubMed, Web of Science, Scopus, and CNKI databases yielded a total of 369 articles. Natural products, lncRNAs, neurological conditions, and neuroprotective effects were used as keywords in the search.